References
- Umehara Y, Kimura T, Okubo T, Sano Y, Nakai K, Oi S, et al. Gastric carcinoma resembling submucosal tumor. Gastric Cancer 1999;2:191-193. https://doi.org/10.1007/s101200050045
- Burkill GJ, Badran M, Al-Muderis O, Meirion Thomas J, Judson IR, Fisher C, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 2003;226:527-532. https://doi.org/10.1148/radiol.2262011880
- Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002;33:669-676. https://doi.org/10.1053/hupa.2002.124116
- Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 2000;96:925-932.
- Schwameis K, Fochtmann A, Schwameis M, Asari R, Schur S, Kostler W, et al. Surgical treatment of GIST: an institutional experience of a high-volume center. Int J Surg 2013;11:801-806. https://doi.org/10.1016/j.ijsu.2013.08.016
- Morinaga N, Sano A, Katayama K, Suzuki K, Kamisaka K, Asao T, et al. Laparoscopic transgastric tumor-everting resection of the gastric submucosal tumor located near the esophagogastric junction. Surg Laparosc Endosc Percutan Tech 2004;14:344-348. https://doi.org/10.1097/01.sle.0000148467.33437.c4
- Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, et al. Treatment of gastric cancer. World J Gastroenterol 2014;20:1635-1649. https://doi.org/10.3748/wjg.v20.i7.1635
- Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992;215:68-77. https://doi.org/10.1097/00000658-199201000-00010
- Hohenberger P, Ronellenfitsch U, Oladeji O, Pink D, Strobel P, Wardelmann E, et al. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 2010;97:1854-1859. https://doi.org/10.1002/bjs.7222
- Eisenberg BL, Harris J, Blanke CD, Demetri GD, Heinrich MC, Watson JC, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol 2009;99:42-47. https://doi.org/10.1002/jso.21160
Cited by
- Concomitant stromal tumor and early cancer of the stomach : What should be done? vol.96, pp.29, 2015, https://doi.org/10.1097/md.0000000000007576
- Subepithelial Tumor-like Gastric Cancer vol.21, pp.2, 2015, https://doi.org/10.7704/kjhugr.2021.0006